synthetic biology

Expanding capabilities in delivering scalable, high-quality synthetic DNA solutions to the global market

Using artificial intelligence and machine learning, a team of researchers engineered an enzyme to degrade toxic PFAS molecules — and they’re only in high school.

Synthetic DNA is increasingly used for gene therapies due to its fast production and improved scalability compared to traditional plasmid-based methods.

Nanobodies that bacteria secrete only in the presence of a biomarker treat inflammatory bowel disease at the site of inflammation.

Engineered peptides that mimic molecules of the innate immune system act synergistically with available drugs to treat Candida albicans in an animal model.

In a mix of innovation and accident, researchers developed a new antibiotic that has broad efficacy across Gram-positive bacteria.

CRISPR biosensing technology provides unambiguous pathogen detection.

Automated synthetic biology workflows enable efficient mRNA-based therapeutic development.

By engineering cells to translate quadruplet codons instead of the standard triplets, scientists expand the possible amino acids that can be integrated into proteins, paving the way for novel protein-based therapeutics and research tools.

Cell membranes act as containers for cell contents. Synthetic cells need them too. Researchers developed a new vessel that uses an unusual border: actin.